pI: 10.3731 |
Length (AA): 302 |
MW (Da): 31962 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 5
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_128045)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G25520 | putative transmembrane protein |
Arabidopsis thaliana | AT5G36290 | hypothetical protein |
Arabidopsis thaliana | AT1G68650 | hypothetical protein |
Brugia malayi | Bm1_41280 | uncharacterized hypothalamus protein HTMP |
Candida albicans | CaO19.11972 | similar to S. cerevisiae YBR187W |
Candida albicans | CaO19.4496 | similar to S. cerevisiae YBR187W |
Caenorhabditis elegans | CELE_Y54F10AL.1 | Protein Y54F10AL.1, isoform B |
Cryptosporidium hominis | Chro.40056 | CG4196-PC |
Cryptosporidium parvum | cgd4_420 | signal peptide + 4 transmembrane domain protein |
Drosophila melanogaster | Dmel_CG42542 | CG42542 gene product from transcript CG42542-RE |
Echinococcus granulosus | EgrG_000867100 | transmembrane protein 165 |
Echinococcus multilocularis | EmuJ_000867100 | transmembrane protein 165 |
Homo sapiens | ENSG00000134851 | transmembrane protein 165 |
Leishmania braziliensis | LbrM.19.0630 | membrane protein, putative |
Leishmania donovani | LdBPK_190310.1 | membrane protein, putative |
Leishmania infantum | LinJ.19.0310 | membrane protein, putative |
Leishmania major | LmjF.19.0310 | membrane protein, putative |
Leishmania mexicana | LmxM.19.0310 | membrane protein, putative |
Loa Loa (eye worm) | LOAG_02681 | hypothetical protein |
Mus musculus | ENSMUSG00000029234 | transmembrane protein 165 |
Mycobacterium tuberculosis | Rv3848 | Probable conserved transmembrane protein |
Mycobacterium ulcerans | MUL_5020 | hypothetical protein |
Neospora caninum | NCLIV_010610 | hypothetical protein |
Oryza sativa | 4345649 | Os08g0433100 |
Oryza sativa | 4350494 | Os11g0472500 |
Oryza sativa | 4346111 | Os08g0528500 |
Onchocerca volvulus | OVOC8708 | Transmembrane protein 165 homolog |
Saccharomyces cerevisiae | YBR187W | Gdt1p |
Schistosoma japonicum | Sjp_0204130 | Transmembrane protein 165, putative |
Schistosoma mansoni | Smp_096780.1 | transmembrane protein htp-1 related |
Schistosoma mansoni | Smp_096780.2 | transmembrane protein htp-1 related |
Schmidtea mediterranea | mk4.016386.00 | Transmembrane protein 165 |
Schmidtea mediterranea | mk4.004497.00 | Transmembrane protein 165 |
Trypanosoma cruzi | TcCLB.506211.50 | membrane protein, putative |
Trypanosoma cruzi | TcCLB.508895.70 | membrane protein, putative |
Toxoplasma gondii | TGME49_319550 | membrane protein C17G8.08c, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
TGME49_319550 | Toxoplasma gondii | Essentiality uncertain | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.